{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-15T12:26:19.028959+00:00",
  "news": [
    {
      "title": "Amgen CEO says weight loss drug can address 'patient persistence issue' - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5\" target=\"_blank\">Amgen CEO says weight loss drug can address 'patient persistence issue'</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2026-01-13T23:46:17+00:00",
      "source": "CNBC"
    },
    {
      "title": "JPM26, Day 2: Novartis pays $50M cash for China biotech program; AZ acquires AI partner - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMifkFVX3lxTE9pRVJtX2RDckRyT2M2N21ZeTNOLXdtbk5OOGsyYzE4T2dEN0tQbXFPaVpVZ1ZBdzF6cjZIUkVMcTEySURaOGZFSW5XUVFMNElqRTU5ODRwSTBCcW5jVUVQRS1wR2NfcjZERUdpWko1ZXl5ODBadzdyQlpCRXJudw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMifkFVX3lxTE9pRVJtX2RDckRyT2M2N21ZeTNOLXdtbk5OOGsyYzE4T2dEN0tQbXFPaVpVZ1ZBdzF6cjZIUkVMcTEySURaOGZFSW5XUVFMNElqRTU5ODRwSTBCcW5jVUVQRS1wR2NfcjZERUdpWko1ZXl5ODBadzdyQlpCRXJudw?oc=5\" target=\"_blank\">JPM26, Day 2: Novartis pays $50M cash for China biotech program; AZ acquires AI partner</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2026-01-13T16:52:30+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen Stock (AMGN) Falls despite Obesity Drug Update — Here’s Wall Street’s Take - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOZmpGTEx4SC1rZkZjYWNMaHJUYWJ2aGZmcE9WWHd0TXd6Z0VVM0lCOU56eTVuQ0FoUnRUQjU5bDlNc1pmSnUyVlZ4c1hocGFDcE9jZ2ZfLWx4c3Q5a3R0MDZOeml6OGJqTWVSU09tWnQtUFFUWnllMWc3QWl2V0FrTHVrd2FSOGh2cjlzbFNlUXRIekZOOWZDSS1RLUVkTzBCbm1Tek44OA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxOZmpGTEx4SC1rZkZjYWNMaHJUYWJ2aGZmcE9WWHd0TXd6Z0VVM0lCOU56eTVuQ0FoUnRUQjU5bDlNc1pmSnUyVlZ4c1hocGFDcE9jZ2ZfLWx4c3Q5a3R0MDZOeml6OGJqTWVSU09tWnQtUFFUWnllMWc3QWl2V0FrTHVrd2FSOGh2cjlzbFNlUXRIekZOOWZDSS1RLUVkTzBCbm1Tek44OA?oc=5\" target=\"_blank\">Amgen Stock (AMGN) Falls despite Obesity Drug Update — Here’s Wall Street’s Take</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2026-01-13T12:23:41+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Amgen’s MariTide Patients Maintain Weight Loss for Two Years - Bloomberg.com",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPMDlGdW5lcW9RY0xFNkRZZi1oam51ZDJ4SlpiRldYWjdFMVgzNlczWkwyZFhtMTQyWWtIUzJucndjRGRMc21zQ3NFbk11YWtUZzExYWFtRzVQRGxrRWNRSzJuTmlPQTBVQmg3TGtpMU1RRmV4ZXNyczJRWF9fdF9jYkh5STdYOGs1enBqQmJ5Tlg3Wms2eHFTbXhaUmx6eHdBU1pkZWs4dHJTaGpwclY3Mg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxPMDlGdW5lcW9RY0xFNkRZZi1oam51ZDJ4SlpiRldYWjdFMVgzNlczWkwyZFhtMTQyWWtIUzJucndjRGRMc21zQ3NFbk11YWtUZzExYWFtRzVQRGxrRWNRSzJuTmlPQTBVQmg3TGtpMU1RRmV4ZXNyczJRWF9fdF9jYkh5STdYOGs1enBqQmJ5Tlg3Wms2eHFTbXhaUmx6eHdBU1pkZWs4dHJTaGpwclY3Mg?oc=5\" target=\"_blank\">Amgen’s MariTide Patients Maintain Weight Loss for Two Years</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg.com</font>",
      "published": "2026-01-13T00:34:00+00:00",
      "source": "Bloomberg.com"
    },
    {
      "title": "AbbVie, Amgen, Lilly Lead Calls for FDA To Update Post-Approval Change Rules - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPTnk0MHNQSE1KRS1sUkhuUG1ERmt2X0hSRklIQUVQYUFjOXRiZGw4dkJNTm4yUnlMSnotUFdCT3U5R2RwVnlVYWQtVzVIYWtOV25fd0xnVDg2czVreU16d3owU3gtRnZlR2ttM2tCQ3UyQ0p2enF0SEtzZlh6TC1CeXh1WlA1NjdhckFoRFBSTi04R05VeUxnQ2JYY3BfMVJOSHNzcWtB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxPTnk0MHNQSE1KRS1sUkhuUG1ERmt2X0hSRklIQUVQYUFjOXRiZGw4dkJNTm4yUnlMSnotUFdCT3U5R2RwVnlVYWQtVzVIYWtOV25fd0xnVDg2czVreU16d3owU3gtRnZlR2ttM2tCQ3UyQ0p2enF0SEtzZlh6TC1CeXh1WlA1NjdhckFoRFBSTi04R05VeUxnQ2JYY3BfMVJOSHNzcWtB?oc=5\" target=\"_blank\">AbbVie, Amgen, Lilly Lead Calls for FDA To Update Post-Approval Change Rules</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2026-01-13T05:02:47+00:00",
      "source": "BioSpace"
    },
    {
      "title": "JPM26: Amgen touts MariTide’s weight loss, T2D potential off Phase II data - Pharmaceutical Technology",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPbkJEOHcwb29nc1h3ZXNQTWZfV0QxS2dReE4ycnk4QU9YaG5haWRNQmMxZmE1UXVnU0twMS11T1hYSUJVdFlwRnRKM3BxQ1dsdXJ6dTFnS0JzQUNIdFhicUVhaTY2RmpGMkFaSjZKazltOXBVUndaQ0dFQldvWF9yc3A1VmZ2UnJ5RnA5Rlh0bF80UzA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxPbkJEOHcwb29nc1h3ZXNQTWZfV0QxS2dReE4ycnk4QU9YaG5haWRNQmMxZmE1UXVnU0twMS11T1hYSUJVdFlwRnRKM3BxQ1dsdXJ6dTFnS0JzQUNIdFhicUVhaTY2RmpGMkFaSjZKazltOXBVUndaQ0dFQldvWF9yc3A1VmZ2UnJ5RnA5Rlh0bF80UzA?oc=5\" target=\"_blank\">JPM26: Amgen touts MariTide’s weight loss, T2D potential off Phase II data</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharmaceutical Technology</font>",
      "published": "2026-01-14T12:33:41+00:00",
      "source": "Pharmaceutical Technology"
    },
    {
      "title": "Ro Partners With Amgen to Study Barriers to Obesity Care, GLP-1 Access - US News Money",
      "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNMjJ5T19WelhYaVozQ3dkeGVzSEJtSUNHcHlvYlpUbXp3UENnZF9WTkNoMUJNRVlJelNGZmkyMG5maTd0Wkl4YXdnRTRaMXdPTVlyY3NEOGI3QWc3Mkd0RGtuemRGWkQ1MHFJZGFvbFdEcHhUVndzVnM2UDFOVGdCdWtERXpNNW83d3E3blZrSzVQYzZqM3ZtZjNOMXBFOEpkNnJlV2NqMXNsbTc2TVRibGtWakcwNGoxRzVGeEQtMF91WjJVd0tfUg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNMjJ5T19WelhYaVozQ3dkeGVzSEJtSUNHcHlvYlpUbXp3UENnZF9WTkNoMUJNRVlJelNGZmkyMG5maTd0Wkl4YXdnRTRaMXdPTVlyY3NEOGI3QWc3Mkd0RGtuemRGWkQ1MHFJZGFvbFdEcHhUVndzVnM2UDFOVGdCdWtERXpNNW83d3E3blZrSzVQYzZqM3ZtZjNOMXBFOEpkNnJlV2NqMXNsbTc2TVRibGtWakcwNGoxRzVGeEQtMF91WjJVd0tfUg?oc=5\" target=\"_blank\">Ro Partners With Amgen to Study Barriers to Obesity Care, GLP-1 Access</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">US News Money</font>",
      "published": "2026-01-13T15:22:00+00:00",
      "source": "US News Money"
    },
    {
      "title": "AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5\" target=\"_blank\">AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2026-01-06T08:00:00+00:00",
      "source": "PR Newswire"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    },
    {
      "title": "Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility - geneonline.com",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5\" target=\"_blank\">Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">geneonline.com</font>",
      "published": "2025-10-08T21:06:00+00:00",
      "source": "geneonline.com"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-14",
      "close": 328.9700012207031
    },
    "history": [
      {
        "date": "2026-01-06",
        "close": 330.1700134277344
      },
      {
        "date": "2026-01-07",
        "close": 341.6400146484375
      },
      {
        "date": "2026-01-08",
        "close": 330.1099853515625
      },
      {
        "date": "2026-01-09",
        "close": 326.1000061035156
      },
      {
        "date": "2026-01-12",
        "close": 325.5400085449219
      },
      {
        "date": "2026-01-13",
        "close": 324.29998779296875
      },
      {
        "date": "2026-01-14",
        "close": 328.9700012207031
      }
    ],
    "name": "Amgen Inc."
  }
}